Silverman Joshua purchased ~$386K in PharmaCyte Biotech Inc stock
PharmaCyte Biotech Inc (PMCB) · Data via SEC EDGAR Form 4
Price Performance · 10 days before → 90 days after trade
▲ = insider buy date
90-day return
-17.9%
Trade Details · Public SEC Filing
Insider
Silverman Joshua
Role
—
Transaction
Open-Market Purchase
Approx. Value
~$386K
Trade Date
Jan 7, 2026
Company
PharmaCyte Biotech Inc
Ticker
PMCBSource
SEC EDGAR Form 4
Why This Trade Stands Out
Strong conviction signal
Scored above average across multiple factors. Roughly 15% of insider trades qualify as Strong.
~$386K purchase
A meaningful investment of personal capital. The average insider purchase is around $150K, putting this in the typical range for serious positions.
2 insiders traded in the same window
When multiple insiders independently buy within 30 days, it's called a cluster. Studies show clustered insider purchases outperform solo trades significantly, because several people with inside knowledge are reaching the same conclusion.
-17.9% in 90 days
Measured from trade date to 90 days later. We track the performance of every insider trade to identify which insiders consistently make profitable moves.
How good is Silverman Joshua at picking stocks?
Full track record: win rate, average return, and performance vs S&P 500
Silverman Joshua wasn't the only one buying.
2 insiders at PharmaCyte Biotech Inc traded within the same 30-day window.
See who else bought · FreeOn January 7, 2026, Silverman Joshua — a corporate insider at PharmaCyte Biotech Inc — filed a Form 4 with the SEC disclosing an open-market purchase of approximately ~$386K in PharmaCyte Biotech Inc (PMCB) stock.
This transaction was part of a cluster — 2 insiders at PharmaCyte Biotech Inc made open-market purchases within the same 30-day window. Cluster activity from multiple independent insiders is one of the most studied patterns in insider trading research.
Under Section 16(a) of the Securities Exchange Act of 1934, corporate insiders must report all open-market stock transactions to the SEC within two business days. These filings — known as Form 4s — are publicly available on the SEC's EDGAR database. VeritySignals filters and scores the full Form 4 stream to surface high-conviction signals like this one.
In the 90 days following this trade, PMCB returned -17.9%
VeritySignals Conviction Analysis
Full Conviction Analysis
Sign up free to see signal strength details, or upgrade for the full 15-factor breakdown.
Get notified the next time Silverman Joshua trades
Free alerts · No credit card · Instant notification
All data sourced from publicly available SEC Form 4 filings via EDGAR · Not financial advice · Past performance does not guarantee future results.
At a Glance
How to Read Insider Trades
What is this?
When company executives buy or sell their own stock, they must report it to the SEC within 2 days. These public filings reveal what the people who know the company best are doing with their own money.
Why does it matter?
Insiders can sell for many reasons (taxes, diversification, expenses), but they generally only buy for one: they think the stock is going up. That's why insider purchases are more predictive than sales.
What makes a trade "strong"?
We score trades on 15+ factors: the insider's role (CEO > director), trade size relative to their salary, whether other insiders also bought (clusters), and historical accuracy of the insider.
Never miss a signal
Get notified when high-conviction insiders buy. Free account, no credit card.
Sign up free